speb/financial-data huggingface dataset:
UTHR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10200000.00
UTHR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 155400000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 115500000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2430000000.00
UTHR income_statement (quarterly, 2026-03-31) — Gross Profit: 648100000.00
UTHR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1500000.00
UTHR income_statement (quarterly, 2026-03-31) — Interest Expense: 3000000.00
UTHR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3000000.00
UTHR income_statement (quarterly, 2026-03-31) — Interest Income: 41800000.00
UTHR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 41800000.00
UTHR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1900000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Inventory: 178300000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5901100000.00
UTHR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 743700000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1317400000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1317400000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 266500000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 509600000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -25000000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1500000000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 274900000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 274900000.00
UTHR income_statement (quarterly, 2026-03-31) — Net Interest Income: 38800000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 875200000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
UTHR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 38800000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -58300000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -5700000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Net PPE: 1840700000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -100800000.00
UTHR cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
UTHR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5785600000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 335400000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 335400000.00
UTHR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 343900000.00
UTHR income_statement (quarterly, 2026-03-31) — Normalized Income: 274900000.00
UTHR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 463300000.00
UTHR cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 61600000.00
UTHR income_statement (quarterly, 2026-03-31) — Operating Income: 325800000.00
UTHR income_statement (quarterly, 2026-03-31) — Operating Revenue: 776200000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 42156223.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 228000000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 100800000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10200000.00
UTHR income_statement (quarterly, 2026-03-31) — Other Gand A: 127900000.00
UTHR income_statement (quarterly, 2026-03-31) — Other Income Expense: -46300000.00
UTHR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 32000000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 233200000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 214000000.00
UTHR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -46300000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 874000000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 498300000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
UTHR income_statement (quarterly, 2026-03-31) — Pretax Income: 318300000.00
UTHR cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 73900000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
UTHR cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -25000000.00
UTHR cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -701700000.00
UTHR cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -100800000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 34600000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Receivables: 312000000.00
UTHR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 133400000.00
UTHR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 22600000.00
UTHR cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
UTHR cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1500000000.00
UTHR income_statement (quarterly, 2026-03-31) — Research And Development: 138200000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 8831800000.00
UTHR income_statement (quarterly, 2026-03-31) — Salaries And Wages: 27500000.00
UTHR cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1576900000.00
UTHR income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 28700000.00
UTHR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 184100000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Share Issued: 77129770.00
UTHR cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
UTHR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 33900000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5901100000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5785600000.00
UTHR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
UTHR income_statement (quarterly, 2026-03-31) — Tax Provision: 43400000.00
UTHR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.14
UTHR balance_sheet (quarterly, 2026-03-31) — Total Assets: 6714200000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5901100000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5901100000.00
UTHR income_statement (quarterly, 2026-03-31) — Total Expenses: 455700000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 813100000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3842200000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 214000000.00
UTHR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 325800000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 34973547.00
UTHR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 5441600000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Work In Process: 35100000.00
UTHR balance_sheet (quarterly, 2026-03-31) — Working Capital: 2272900000.00
UTI cash_flow (annual, 2021-09-30) — Asset Impairment Charge: 1718000.00
UTI cash_flow (annual, 2021-09-30) — Change In Account Payable: 1790000.00
UTI cash_flow (annual, 2021-09-30) — Change In Accrued Expense: 2025000.00
UTI cash_flow (annual, 2021-09-30) — Change In Other Current Assets: -768000.00
UTI cash_flow (annual, 2021-09-30) — Change In Payable: 1790000.00
UTI cash_flow (annual, 2021-09-30) — Common Stock Issuance: 0.00
UTI income_statement (annual, 2021-09-30) — Depreciation Amortization Depletion Income Statement: 796000.00
UTI income_statement (annual, 2021-09-30) — Depreciation And Amortization In Income Statement: 796000.00
UTI income_statement (annual, 2021-09-30) — Earnings From Equity Interest: 0.00
UTI cash_flow (annual, 2021-09-30) — Earnings Losses From Equity Investments: 0.00
UTI income_statement (annual, 2021-09-30) — Impairment Of Capital Assets: 0.00
UTI cash_flow (annual, 2021-09-30) — Issuance Of Capital Stock: 0.00
UTI cash_flow (annual, 2021-09-30) — Long Term Debt Issuance: 31150000.00
UTI cash_flow (annual, 2021-09-30) — Net Common Stock Issuance: 0.00
UTI cash_flow (annual, 2021-09-30) — Net Other Investing Changes: 427000.00
UTI income_statement (annual, 2021-09-30) — Preferred Stock Dividends: 5250000.00
UTI cash_flow (annual, 2021-09-30) — Sale Of Business: 277000.00
UTI cash_flow (annual, 2021-09-30) — Sale Of PPE: 280000.00
UTI income_statement (annual, 2021-09-30) — Special Income Charges: 0.00
UTI income_statement (annual, 2021-09-30) — Total Unusual Items: 0.00
UTI income_statement (annual, 2021-09-30) — Total Unusual Items Excluding Goodwill: 0.00
UTI income_statement (annual, 2022-09-30) — +Operating Expense: 189158000.00
UTI income_statement (annual, 2022-09-30) — +Total Revenue: 418765000.00
UTI balance_sheet (annual, 2022-09-30) — Accounts Payable: 21746000.00
UTI balance_sheet (annual, 2022-09-30) — Accounts Receivable: 18931000.00
UTI balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -194425000.00
UTI balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 214853000.00
UTI cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 2000000.00
UTI income_statement (annual, 2022-09-30) — Basic Average Shares: 33218000.00
UTI income_statement (annual, 2022-09-30) — Basic EPS: 0.39
UTI cash_flow (annual, 2022-09-30) — Beginning Cash Position: 133721000.00
UTI balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 126244000.00
UTI cash_flow (annual, 2022-09-30) — Capital Expenditure: -79450000.00
UTI balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 142261000.00
UTI balance_sheet (annual, 2022-09-30) — Capital Stock: 3000.00
UTI balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 66452000.00
UTI balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 95370000.00
UTI cash_flow (annual, 2022-09-30) — Cash Dividends Paid: -5159000.00
UTI cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 12585000.00
UTI cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -134597000.00
UTI cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: 46031000.00
UTI cash_flow (annual, 2022-09-30) — Change In Account Payable: 5652000.00
UTI cash_flow (annual, 2022-09-30) — Change In Accrued Expense: 1685000.00
UTI cash_flow (annual, 2022-09-30) — Change In Other Current Assets: -1673000.00
UTI cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: -18237000.00
UTI cash_flow (annual, 2022-09-30) — Change In Other Working Capital: -6719000.00
UTI cash_flow (annual, 2022-09-30) — Change In Payable: 5652000.00
UTI cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 7115000.00
UTI cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -1737000.00
UTI cash_flow (annual, 2022-09-30) — Change In Receivables: 816000.00
UTI cash_flow (annual, 2022-09-30) — Change In Working Capital: -18762000.00
UTI cash_flow (annual, 2022-09-30) — Changes In Account Receivables: 564000.00
UTI cash_flow (annual, 2022-09-30) — Changes In Cash: -67269000.00
UTI balance_sheet (annual, 2022-09-30) — Common Stock: 3000.00
UTI balance_sheet (annual, 2022-09-30) — Common Stock Equity: 215397000.00
UTI cash_flow (annual, 2022-09-30) — Common Stock Issuance: 0.00
UTI balance_sheet (annual, 2022-09-30) — Construction In Progress: 16359000.00
UTI income_statement (annual, 2022-09-30) — Cost Of Revenue: 207233000.00
UTI balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 16504000.00
UTI balance_sheet (annual, 2022-09-30) — Current Assets: 135953000.00
UTI balance_sheet (annual, 2022-09-30) — Current Capital Lease Obligation: 12959000.00
UTI balance_sheet (annual, 2022-09-30) — Current Debt: 1115000.00
UTI balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 14074000.00
UTI balance_sheet (annual, 2022-09-30) — Current Deferred Liabilities: 54223000.00
UTI balance_sheet (annual, 2022-09-30) — Current Deferred Revenue: 54223000.00
UTI balance_sheet (annual, 2022-09-30) — Current Liabilities: 137722000.00
UTI cash_flow (annual, 2022-09-30) — Deferred Income Tax: -6014000.00
UTI cash_flow (annual, 2022-09-30) — Deferred Tax: -6014000.00
UTI cash_flow (annual, 2022-09-30) — Depreciation: 32777000.00
UTI cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 32777000.00
UTI income_statement (annual, 2022-09-30) — Depreciation Amortization Depletion Income Statement: 1174000.00
UTI cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 32777000.00
UTI income_statement (annual, 2022-09-30) — Depreciation And Amortization In Income Statement: 1174000.00
UTI income_statement (annual, 2022-09-30) — Diluted Average Shares: 33743000.00
UTI income_statement (annual, 2022-09-30) — Diluted EPS: 0.38
UTI income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 12842000.00
UTI income_statement (annual, 2022-09-30) — EBIT: 22443000.00
UTI income_statement (annual, 2022-09-30) — EBITDA: 55220000.00
UTI cash_flow (annual, 2022-09-30) — End Cash Position: 66452000.00
UTI cash_flow (annual, 2022-09-30) — Financing Cash Flow: 12585000.00
UTI cash_flow (annual, 2022-09-30) — Free Cash Flow: -33419000.00
UTI cash_flow (annual, 2022-09-30) — Gain Loss On Investment Securities: 2492000.00
UTI balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: 2213000.00
UTI income_statement (annual, 2022-09-30) — General And Administrative Expense: 134438000.00
UTI balance_sheet (annual, 2022-09-30) — Goodwill: 16859000.00
UTI balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 31074000.00
UTI balance_sheet (annual, 2022-09-30) — Gross PPE: 540755000.00
UTI income_statement (annual, 2022-09-30) — Gross Profit: 211532000.00
UTI income_statement (annual, 2022-09-30) — Impairment Of Capital Assets: 2000000.00
UTI cash_flow (annual, 2022-09-30) — Income Tax Paid Supplemental Data: -859000.00
UTI income_statement (annual, 2022-09-30) — Interest Expense: 2002000.00
UTI income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 2002000.00
UTI income_statement (annual, 2022-09-30) — Interest Income: 507000.00
UTI income_statement (annual, 2022-09-30) — Interest Income Non Operating: 507000.00
UTI cash_flow (annual, 2022-09-30) — Interest Paid Supplemental Data: -1937000.00
UTI balance_sheet (annual, 2022-09-30) — Invested Capital: 282935000.00
UTI cash_flow (annual, 2022-09-30) — Investing Cash Flow: -134597000.00
UTI cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 0.00
UTI cash_flow (annual, 2022-09-30) — Issuance Of Debt: 38000000.00
UTI balance_sheet (annual, 2022-09-30) — Land And Improvements: 16603000.00
UTI balance_sheet (annual, 2022-09-30) — Leases: 86751000.00
UTI balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 129302000.00
UTI balance_sheet (annual, 2022-09-30) — Long Term Debt: 66423000.00
UTI balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 195725000.00
UTI cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 38000000.00
UTI cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -19227000.00
UTI balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 45508000.00
UTI cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: -26326000.00
UTI cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 0.00
UTI balance_sheet (annual, 2022-09-30) — Net Debt: 1086000.00
UTI income_statement (annual, 2022-09-30) — Net Income: 25848000.00
UTI income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 12842000.00
UTI income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 25848000.00
UTI income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 25848000.00
UTI income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 25848000.00
UTI cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 25848000.00
UTI income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 25848000.00
UTI income_statement (annual, 2022-09-30) — Net Interest Income: -1495000.00
UTI cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: -28821000.00
UTI cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 18773000.00
UTI cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 18773000.00
UTI income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -1495000.00
UTI cash_flow (annual, 2022-09-30) — Net Other Financing Charges: -1029000.00
UTI balance_sheet (annual, 2022-09-30) — Net PPE: 346330000.00
UTI cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -79450000.00
UTI cash_flow (annual, 2022-09-30) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (annual, 2022-09-30) — Net Short Term Debt Issuance: 0.00
UTI balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 184323000.00
UTI balance_sheet (annual, 2022-09-30) — Non Current Deferred Assets: 3365000.00
UTI balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 0.00
UTI balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Assets: 3365000.00
UTI balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Liabilities: 0.00
UTI balance_sheet (annual, 2022-09-30) — Non Current Note Receivables: 30231000.00
UTI income_statement (annual, 2022-09-30) — Normalized EBITDA: 55220000.00
UTI income_statement (annual, 2022-09-30) — Normalized Income: 25848000.00
UTI balance_sheet (annual, 2022-09-30) — Notes Receivable: 5641000.00
UTI cash_flow (annual, 2022-09-30) — Operating Cash Flow: 46031000.00
UTI cash_flow (annual, 2022-09-30) — Operating Gains Losses: 2492000.00
UTI income_statement (annual, 2022-09-30) — Operating Income: 22374000.00
UTI income_statement (annual, 2022-09-30) — Operating Revenue: 418765000.00
UTI balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 33775000.00
UTI balance_sheet (annual, 2022-09-30) — Other Current Assets: 8809000.00
UTI balance_sheet (annual, 2022-09-30) — Other Current Borrowings: 1115000.00
UTI balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 2745000.00
UTI balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: 2213000.00
UTI income_statement (annual, 2022-09-30) — Other Gand A: 40884000.00
UTI income_statement (annual, 2022-09-30) — Other Income Expense: -438000.00
UTI balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 14215000.00
UTI cash_flow (annual, 2022-09-30) — Other Non Cash Items: 843000.00
UTI balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 5958000.00
UTI balance_sheet (annual, 2022-09-30) — Other Non Current Liabilities: 4067000.00
UTI income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: -438000.00
UTI balance_sheet (annual, 2022-09-30) — Other Properties: 249290000.00
UTI balance_sheet (annual, 2022-09-30) — Other Receivables: 3153000.00
UTI balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 28918000.00
UTI income_statement (annual, 2022-09-30) — Otherunder Preferred Stock Dividend: 7847000.00
UTI balance_sheet (annual, 2022-09-30) — Payables: 21746000.00
UTI balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 38250000.00
UTI balance_sheet (annual, 2022-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 28430000.00
UTI balance_sheet (annual, 2022-09-30) — Preferred Stock: 0.00
UTI cash_flow (annual, 2022-09-30) — Preferred Stock Dividend Paid: -5159000.00
UTI income_statement (annual, 2022-09-30) — Preferred Stock Dividends: 5159000.00
UTI cash_flow (annual, 2022-09-30) — Preferred Stock Payments: 0.00
UTI balance_sheet (annual, 2022-09-30) — Prepaid Assets: 6139000.00
UTI income_statement (annual, 2022-09-30) — Pretax Income: 20441000.00
UTI balance_sheet (annual, 2022-09-30) — Properties: 0.00
UTI cash_flow (annual, 2022-09-30) — Provisionand Write Offof Assets: 2510000.00
UTI cash_flow (annual, 2022-09-30) — Purchase Of Business: -26514000.00
UTI cash_flow (annual, 2022-09-30) — Purchase Of Investment: -28821000.00
UTI cash_flow (annual, 2022-09-30) — Purchase Of PPE: -79450000.00
UTI balance_sheet (annual, 2022-09-30) — Receivables: 22091000.00
UTI balance_sheet (annual, 2022-09-30) — Receivables Adjustments Allowances: -5634000.00
UTI income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 207233000.00
UTI income_statement (annual, 2022-09-30) — Reconciled Depreciation: 32777000.00
UTI income_statement (annual, 2022-09-30) — Rent Expense Supplemental: 35408000.00
UTI cash_flow (annual, 2022-09-30) — Repayment Of Debt: -19227000.00
UTI cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (annual, 2022-09-30) — Restricted Cash: 3544000.00
UTI balance_sheet (annual, 2022-09-30) — Retained Earnings: -1307000.00
UTI income_statement (annual, 2022-09-30) — Salaries And Wages: 93554000.00
UTI cash_flow (annual, 2022-09-30) — Sale Of Business: 188000.00
UTI cash_flow (annual, 2022-09-30) — Sale Of Investment: 0.00
UTI cash_flow (annual, 2022-09-30) — Sale Of PPE: 7000.00
UTI income_statement (annual, 2022-09-30) — Selling And Marketing Expense: 51546000.00
UTI income_statement (annual, 2022-09-30) — Selling General And Administration: 189158000.00
UTI balance_sheet (annual, 2022-09-30) — Share Issued: 33857000.00
UTI cash_flow (annual, 2022-09-30) — Short Term Debt Issuance: 0.00
UTI income_statement (annual, 2022-09-30) — Special Income Charges: -2000000.00
UTI cash_flow (annual, 2022-09-30) — Stock Based Compensation: 4337000.00
UTI balance_sheet (annual, 2022-09-30) — Stockholders Equity: 215397000.00
UTI balance_sheet (annual, 2022-09-30) — Tangible Book Value: 184323000.00
UTI income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (annual, 2022-09-30) — Tax Provision: -5407000.00
UTI income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.21
UTI balance_sheet (annual, 2022-09-30) — Taxes Receivable: 0.00
UTI balance_sheet (annual, 2022-09-30) — Total Assets: 552911000.00
UTI balance_sheet (annual, 2022-09-30) — Total Capitalization: 281820000.00
UTI balance_sheet (annual, 2022-09-30) — Total Debt: 209799000.00
UTI balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 215397000.00
UTI income_statement (annual, 2022-09-30) — Total Expenses: 396391000.00
UTI balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 337514000.00
UTI balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 416958000.00
UTI balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 199792000.00
UTI income_statement (annual, 2022-09-30) — Total Operating Income As Reported: 22374000.00
UTI income_statement (annual, 2022-09-30) — Total Unusual Items: -2000000.00
UTI income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -2000000.00
UTI balance_sheet (annual, 2022-09-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (annual, 2022-09-30) — Treasury Stock: 365000.00
UTI balance_sheet (annual, 2022-09-30) — Working Capital: -1769000.00
UTI income_statement (annual, 2023-09-30) — +Operating Expense: 256139000.00
UTI income_statement (annual, 2023-09-30) — +Total Revenue: 607408000.00
UTI balance_sheet (annual, 2023-09-30) — Accounts Payable: 14438000.00
UTI balance_sheet (annual, 2023-09-30) — Accounts Receivable: 29616000.00
UTI balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -186364000.00
UTI balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 217920000.00
UTI cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 3319000.00
UTI income_statement (annual, 2023-09-30) — Basic Average Shares: 33985000.00
UTI income_statement (annual, 2023-09-30) — Basic EPS: 0.13
UTI cash_flow (annual, 2023-09-30) — Beginning Cash Position: 69996000.00
UTI balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 160920000.00
UTI cash_flow (annual, 2023-09-30) — Capital Expenditure: -56685000.00
UTI balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 187507000.00
UTI balance_sheet (annual, 2023-09-30) — Capital Stock: 3000.00
UTI balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 151547000.00
UTI balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 151547000.00
UTI cash_flow (annual, 2023-09-30) — Cash Dividends Paid: -5069000.00
UTI cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 81846000.00
UTI cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -44066000.00
UTI cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: 49148000.00
UTI cash_flow (annual, 2023-09-30) — Change In Other Current Assets: 740000.00
UTI cash_flow (annual, 2023-09-30) — Change In Other Current Liabilities: -21183000.00
UTI cash_flow (annual, 2023-09-30) — Change In Other Working Capital: 11202000.00
UTI cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: -5718000.00
UTI cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: -2013000.00
UTI cash_flow (annual, 2023-09-30) — Change In Receivables: -4985000.00
UTI cash_flow (annual, 2023-09-30) — Change In Working Capital: -22697000.00
UTI cash_flow (annual, 2023-09-30) — Changes In Account Receivables: -4194000.00
UTI cash_flow (annual, 2023-09-30) — Changes In Cash: 86928000.00
UTI balance_sheet (annual, 2023-09-30) — Common Stock: 3000.00
UTI balance_sheet (annual, 2023-09-30) — Common Stock Equity: 225967000.00
UTI balance_sheet (annual, 2023-09-30) — Construction In Progress: 9061000.00
UTI income_statement (annual, 2023-09-30) — Cost Of Revenue: 329870000.00
UTI balance_sheet (annual, 2023-09-30) — Current Accrued Expenses: 19171000.00
UTI balance_sheet (annual, 2023-09-30) — Current Assets: 204985000.00
UTI balance_sheet (annual, 2023-09-30) — Current Capital Lease Obligation: 22481000.00
UTI balance_sheet (annual, 2023-09-30) — Current Debt: 2517000.00
UTI balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 24998000.00
UTI balance_sheet (annual, 2023-09-30) — Current Deferred Liabilities: 85738000.00
UTI balance_sheet (annual, 2023-09-30) — Current Deferred Revenue: 85738000.00
UTI balance_sheet (annual, 2023-09-30) — Current Liabilities: 184700000.00
UTI cash_flow (annual, 2023-09-30) — Deferred Income Tax: 4636000.00
UTI cash_flow (annual, 2023-09-30) — Deferred Tax: 4636000.00
UTI cash_flow (annual, 2023-09-30) — Depreciation: 45819000.00
UTI cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 45819000.00
UTI cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 45819000.00
UTI income_statement (annual, 2023-09-30) — Diluted Average Shares: 34479000.00
UTI income_statement (annual, 2023-09-30) — Diluted EPS: 0.13
UTI income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: 4541000.00
UTI income_statement (annual, 2023-09-30) — EBIT: 27743000.00
UTI income_statement (annual, 2023-09-30) — EBITDA: 73562000.00
UTI cash_flow (annual, 2023-09-30) — End Cash Position: 156924000.00
UTI cash_flow (annual, 2023-09-30) — Financing Cash Flow: 81846000.00
UTI cash_flow (annual, 2023-09-30) — Free Cash Flow: -7537000.00
UTI cash_flow (annual, 2023-09-30) — Gain Loss On Investment Securities: 250000.00
UTI balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: 2463000.00
UTI income_statement (annual, 2023-09-30) — General And Administrative Expense: 183972000.00
UTI balance_sheet (annual, 2023-09-30) — Goodwill: 28459000.00
UTI balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 47434000.00
UTI balance_sheet (annual, 2023-09-30) — Gross PPE: 629367000.00
UTI income_statement (annual, 2023-09-30) — Gross Profit: 277538000.00
UTI income_statement (annual, 2023-09-30) — Impairment Of Capital Assets: 0.00
UTI cash_flow (annual, 2023-09-30) — Income Tax Paid Supplemental Data: 658000.00
UTI income_statement (annual, 2023-09-30) — Interest Expense: 9656000.00
UTI income_statement (annual, 2023-09-30) — Interest Expense Non Operating: 9656000.00
UTI income_statement (annual, 2023-09-30) — Interest Income: 5861000.00
UTI income_statement (annual, 2023-09-30) — Interest Income Non Operating: 5861000.00
UTI cash_flow (annual, 2023-09-30) — Interest Paid Supplemental Data: 9069000.00
UTI balance_sheet (annual, 2023-09-30) — Invested Capital: 388084000.00
UTI cash_flow (annual, 2023-09-30) — Investing Cash Flow: -44066000.00
UTI cash_flow (annual, 2023-09-30) — Issuance Of Debt: 90000000.00
UTI balance_sheet (annual, 2023-09-30) — Land And Improvements: 25601000.00
UTI balance_sheet (annual, 2023-09-30) — Leases: 87525000.00
UTI balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 165026000.00
UTI balance_sheet (annual, 2023-09-30) — Long Term Debt: 159600000.00
UTI balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 324626000.00
UTI cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 0.00
UTI cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -1788000.00
UTI balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 51230000.00
UTI cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: -16381000.00
UTI balance_sheet (annual, 2023-09-30) — Net Debt: 10570000.00
UTI income_statement (annual, 2023-09-30) — Net Income: 12322000.00
UTI income_statement (annual, 2023-09-30) — Net Income Common Stockholders: 4541000.00
UTI income_statement (annual, 2023-09-30) — Net Income Continuous Operations: 12322000.00
UTI income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: 12322000.00
UTI income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: 12322000.00
UTI cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: 12322000.00
UTI income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: 12322000.00
UTI income_statement (annual, 2023-09-30) — Net Interest Income: -3795000.00
UTI cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 29000000.00
UTI cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: 88212000.00
UTI cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: -1788000.00
UTI income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: -3795000.00
UTI cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -1297000.00
UTI balance_sheet (annual, 2023-09-30) — Net PPE: 443003000.00
UTI cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -56685000.00
UTI cash_flow (annual, 2023-09-30) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (annual, 2023-09-30) — Net Short Term Debt Issuance: 90000000.00
UTI balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 178533000.00
UTI balance_sheet (annual, 2023-09-30) — Non Current Deferred Assets: 3768000.00
UTI balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 663000.00
UTI balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Assets: 3768000.00
UTI balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Liabilities: 663000.00
UTI balance_sheet (annual, 2023-09-30) — Non Current Note Receivables: 30672000.00
UTI income_statement (annual, 2023-09-30) — Normalized EBITDA: 73562000.00
UTI income_statement (annual, 2023-09-30) — Normalized Income: 12322000.00
UTI balance_sheet (annual, 2023-09-30) — Notes Receivable: 5991000.00
UTI cash_flow (annual, 2023-09-30) — Operating Cash Flow: 49148000.00
UTI cash_flow (annual, 2023-09-30) — Operating Gains Losses: 250000.00
UTI income_statement (annual, 2023-09-30) — Operating Income: 21399000.00
UTI income_statement (annual, 2023-09-30) — Operating Revenue: 607408000.00
UTI balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 34075000.00
UTI balance_sheet (annual, 2023-09-30) — Other Current Assets: 7497000.00
UTI balance_sheet (annual, 2023-09-30) — Other Current Borrowings: 2517000.00
UTI balance_sheet (annual, 2023-09-30) — Other Current Liabilities: 4023000.00
UTI balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: 2463000.00
UTI income_statement (annual, 2023-09-30) — Other Gand A: 53569000.00
UTI income_statement (annual, 2023-09-30) — Other Income Expense: 483000.00
UTI balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 18975000.00
UTI cash_flow (annual, 2023-09-30) — Other Non Cash Items: 1651000.00
UTI balance_sheet (annual, 2023-09-30) — Other Non Current Assets: 10823000.00
UTI balance_sheet (annual, 2023-09-30) — Other Non Current Liabilities: 4729000.00
UTI income_statement (annual, 2023-09-30) — Other Non Operating Income Expenses: 483000.00
UTI balance_sheet (annual, 2023-09-30) — Other Properties: 295030000.00
UTI balance_sheet (annual, 2023-09-30) — Other Receivables: 3858000.00
UTI balance_sheet (annual, 2023-09-30) — Other Short Term Investments: 0.00
UTI income_statement (annual, 2023-09-30) — Otherunder Preferred Stock Dividend: 2712000.00
UTI balance_sheet (annual, 2023-09-30) — Payables: 14438000.00
UTI balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 33609000.00
UTI balance_sheet (annual, 2023-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 36332000.00
UTI balance_sheet (annual, 2023-09-30) — Preferred Stock: 0.00
UTI cash_flow (annual, 2023-09-30) — Preferred Stock Dividend Paid: -5069000.00
UTI income_statement (annual, 2023-09-30) — Preferred Stock Dividends: 5069000.00
UTI cash_flow (annual, 2023-09-30) — Preferred Stock Payments: 0.00
UTI balance_sheet (annual, 2023-09-30) — Prepaid Assets: 9412000.00
UTI income_statement (annual, 2023-09-30) — Pretax Income: 18087000.00
UTI cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (annual, 2023-09-30) — Properties: 0.00
UTI cash_flow (annual, 2023-09-30) — Provisionand Write Offof Assets: 3319000.00
UTI cash_flow (annual, 2023-09-30) — Purchase Of Business: -16381000.00
UTI cash_flow (annual, 2023-09-30) — Purchase Of Investment: 0.00
UTI cash_flow (annual, 2023-09-30) — Purchase Of PPE: -56685000.00
UTI balance_sheet (annual, 2023-09-30) — Receivables: 31152000.00
UTI balance_sheet (annual, 2023-09-30) — Receivables Adjustments Allowances: -9053000.00
UTI income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 329870000.00
UTI income_statement (annual, 2023-09-30) — Reconciled Depreciation: 45819000.00
UTI income_statement (annual, 2023-09-30) — Rent Expense Supplemental: 49410000.00
UTI cash_flow (annual, 2023-09-30) — Repayment Of Debt: -1788000.00
UTI cash_flow (annual, 2023-09-30) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (annual, 2023-09-30) — Restricted Cash: 5377000.00
UTI balance_sheet (annual, 2023-09-30) — Retained Earnings: 5946000.00
UTI income_statement (annual, 2023-09-30) — Salaries And Wages: 130403000.00
UTI cash_flow (annual, 2023-09-30) — Sale Of Business: 0.00
UTI cash_flow (annual, 2023-09-30) — Sale Of Investment: 29000000.00
UTI income_statement (annual, 2023-09-30) — Selling And Marketing Expense: 72167000.00
UTI income_statement (annual, 2023-09-30) — Selling General And Administration: 256139000.00
UTI balance_sheet (annual, 2023-09-30) — Share Issued: 34157000.00
UTI cash_flow (annual, 2023-09-30) — Short Term Debt Issuance: 90000000.00
UTI income_statement (annual, 2023-09-30) — Special Income Charges: 0.00
UTI cash_flow (annual, 2023-09-30) — Stock Based Compensation: 3848000.00
UTI balance_sheet (annual, 2023-09-30) — Stockholders Equity: 225967000.00
UTI balance_sheet (annual, 2023-09-30) — Tangible Book Value: 178533000.00
UTI income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (annual, 2023-09-30) — Tax Provision: 5765000.00
UTI income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.32
UTI balance_sheet (annual, 2023-09-30) — Taxes Receivable: 740000.00
UTI balance_sheet (annual, 2023-09-30) — Total Assets: 740685000.00
UTI balance_sheet (annual, 2023-09-30) — Total Capitalization: 385567000.00
UTI balance_sheet (annual, 2023-09-30) — Total Debt: 349624000.00
UTI balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 225967000.00
UTI income_statement (annual, 2023-09-30) — Total Expenses: 586009000.00
UTI balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 514718000.00
UTI balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 535700000.00
UTI balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 330018000.00
UTI income_statement (annual, 2023-09-30) — Total Operating Income As Reported: 21399000.00
UTI income_statement (annual, 2023-09-30) — Total Unusual Items: 0.00
UTI income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: 0.00
UTI balance_sheet (annual, 2023-09-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (annual, 2023-09-30) — Treasury Stock: 365000.00
UTI balance_sheet (annual, 2023-09-30) — Working Capital: 20285000.00
UTI income_statement (annual, 2024-09-30) — +Operating Expense: 289267000.00
UTI income_statement (annual, 2024-09-30) — +Total Revenue: 732687000.00
UTI balance_sheet (annual, 2024-09-30) — Accounts Payable: 26273000.00
UTI balance_sheet (annual, 2024-09-30) — Accounts Receivable: 35290000.00
UTI balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -208204000.00
UTI balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 220976000.00
UTI cash_flow (annual, 2024-09-30) — Asset Impairment Charge: 0.00
UTI cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: -5066000.00
UTI income_statement (annual, 2024-09-30) — Basic Average Shares: 49429000.00
UTI income_statement (annual, 2024-09-30) — Basic EPS: 0.77
UTI cash_flow (annual, 2024-09-30) — Beginning Cash Position: 156924000.00
UTI balance_sheet (annual, 2024-09-30) — Buildings And Improvements: 165667000.00
UTI cash_flow (annual, 2024-09-30) — Capital Expenditure: -24298000.00
UTI balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 169041000.00
UTI balance_sheet (annual, 2024-09-30) — Capital Stock: 5000.00
UTI balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 161900000.00
UTI balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 161900000.00
UTI cash_flow (annual, 2024-09-30) — Cash Dividends Paid: -1097000.00
UTI cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
UTI cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: -51345000.00
UTI cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: -24002000.00
UTI cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: 85895000.00
UTI cash_flow (annual, 2024-09-30) — Change In Other Current Liabilities: -23215000.00
UTI cash_flow (annual, 2024-09-30) — Change In Other Working Capital: 3316000.00
UTI cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: 13195000.00
UTI cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: -3651000.00
UTI cash_flow (annual, 2024-09-30) — Change In Receivables: -17927000.00
UTI cash_flow (annual, 2024-09-30) — Change In Working Capital: -28282000.00
UTI cash_flow (annual, 2024-09-30) — Changes In Account Receivables: -12123000.00
UTI cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: -2387000.00
UTI cash_flow (annual, 2024-09-30) — Changes In Cash: 10548000.00
UTI balance_sheet (annual, 2024-09-30) — Common Stock: 5000.00
UTI balance_sheet (annual, 2024-09-30) — Common Stock Equity: 260231000.00
UTI balance_sheet (annual, 2024-09-30) — Construction In Progress: 6314000.00
UTI income_statement (annual, 2024-09-30) — Cost Of Revenue: 384529000.00
UTI balance_sheet (annual, 2024-09-30) — Current Accrued Expenses: 21933000.00
UTI balance_sheet (annual, 2024-09-30) — Current Assets: 221951000.00
UTI balance_sheet (annual, 2024-09-30) — Current Capital Lease Obligation: 22210000.00
UTI balance_sheet (annual, 2024-09-30) — Current Debt: 2697000.00
UTI balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 24907000.00
UTI balance_sheet (annual, 2024-09-30) — Current Deferred Liabilities: 92538000.00
UTI balance_sheet (annual, 2024-09-30) — Current Deferred Revenue: 92538000.00
UTI balance_sheet (annual, 2024-09-30) — Current Liabilities: 204963000.00
UTI cash_flow (annual, 2024-09-30) — Deferred Income Tax: 4439000.00
UTI cash_flow (annual, 2024-09-30) — Deferred Tax: 4439000.00
UTI cash_flow (annual, 2024-09-30) — Depreciation: 51185000.00
UTI cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 51185000.00
UTI cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 51185000.00
UTI income_statement (annual, 2024-09-30) — Diluted Average Shares: 50851000.00
UTI income_statement (annual, 2024-09-30) — Diluted EPS: 0.75
UTI income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: 38049000.00
UTI income_statement (annual, 2024-09-30) — EBIT: 65701000.00
UTI income_statement (annual, 2024-09-30) — EBITDA: 116886000.00
UTI cash_flow (annual, 2024-09-30) — End Cash Position: 167472000.00
UTI cash_flow (annual, 2024-09-30) — Financing Cash Flow: -51345000.00
UTI cash_flow (annual, 2024-09-30) — Free Cash Flow: 61597000.00
UTI cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: -1357000.00
UTI balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 1106000.00
UTI income_statement (annual, 2024-09-30) — General And Administrative Expense: 211006000.00
UTI balance_sheet (annual, 2024-09-30) — Goodwill: 28459000.00
UTI balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 46688000.00
UTI balance_sheet (annual, 2024-09-30) — Gross PPE: 631779000.00
UTI income_statement (annual, 2024-09-30) — Gross Profit: 348158000.00
UTI cash_flow (annual, 2024-09-30) — Income Tax Paid Supplemental Data: 10683000.00
UTI income_statement (annual, 2024-09-30) — Interest Expense: 9471000.00
UTI income_statement (annual, 2024-09-30) — Interest Expense Non Operating: 9471000.00
UTI income_statement (annual, 2024-09-30) — Interest Income: 6314000.00
UTI income_statement (annual, 2024-09-30) — Interest Income Non Operating: 6314000.00
UTI cash_flow (annual, 2024-09-30) — Interest Paid Supplemental Data: 10391000.00
UTI balance_sheet (annual, 2024-09-30) — Invested Capital: 385935000.00
UTI cash_flow (annual, 2024-09-30) — Investing Cash Flow: -24002000.00
UTI cash_flow (annual, 2024-09-30) — Issuance Of Debt: 41000000.00
UTI balance_sheet (annual, 2024-09-30) — Land And Improvements: 25601000.00
UTI balance_sheet (annual, 2024-09-30) — Leases: 94473000.00
UTI balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 146831000.00
UTI balance_sheet (annual, 2024-09-30) — Long Term Debt: 123007000.00
UTI balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 269838000.00
UTI cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 0.00
UTI cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: -36000000.00
UTI cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -77518000.00
UTI balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 51045000.00
UTI cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: 0.00
UTI cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
UTI income_statement (annual, 2024-09-30) — Net Income: 42001000.00
UTI income_statement (annual, 2024-09-30) — Net Income Common Stockholders: 38049000.00
UTI income_statement (annual, 2024-09-30) — Net Income Continuous Operations: 42001000.00
UTI income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 42001000.00
UTI income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 42001000.00
UTI cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: 42001000.00
UTI income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: 42001000.00
UTI income_statement (annual, 2024-09-30) — Net Interest Income: -3157000.00
UTI cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: 0.00
UTI cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -36518000.00
UTI cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -77518000.00
UTI income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: -3157000.00
UTI cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -2227000.00
UTI cash_flow (annual, 2024-09-30) — Net Other Investing Changes: 296000.00
UTI cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 35000.00
UTI balance_sheet (annual, 2024-09-30) — Net PPE: 423575000.00
UTI cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -24298000.00
UTI cash_flow (annual, 2024-09-30) — Net Preferred Stock Issuance: -11503000.00
UTI cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (annual, 2024-09-30) — Net Short Term Debt Issuance: 41000000.00
UTI balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 213543000.00
UTI balance_sheet (annual, 2024-09-30) — Non Current Deferred Assets: 3563000.00
UTI balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 4696000.00
UTI balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Assets: 3563000.00
UTI balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Liabilities: 4696000.00
UTI balance_sheet (annual, 2024-09-30) — Non Current Note Receivables: 36267000.00
UTI income_statement (annual, 2024-09-30) — Normalized EBITDA: 116886000.00
UTI income_statement (annual, 2024-09-30) — Normalized Income: 42001000.00
UTI balance_sheet (annual, 2024-09-30) — Notes Receivable: 6200000.00
UTI cash_flow (annual, 2024-09-30) — Operating Cash Flow: 85895000.00
UTI cash_flow (annual, 2024-09-30) — Operating Gains Losses: -1357000.00
UTI income_statement (annual, 2024-09-30) — Operating Income: 58891000.00
UTI income_statement (annual, 2024-09-30) — Operating Revenue: 732687000.00
UTI balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 53816995.00
UTI balance_sheet (annual, 2024-09-30) — Other Current Assets: 5238000.00
UTI balance_sheet (annual, 2024-09-30) — Other Current Borrowings: 2697000.00
UTI balance_sheet (annual, 2024-09-30) — Other Current Liabilities: 3652000.00
UTI balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: 1106000.00
UTI income_statement (annual, 2024-09-30) — Other Gand A: 63304000.00
UTI income_statement (annual, 2024-09-30) — Other Income Expense: 496000.00
UTI balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 18229000.00
UTI cash_flow (annual, 2024-09-30) — Other Non Cash Items: 1802000.00
UTI balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 12531000.00
UTI balance_sheet (annual, 2024-09-30) — Other Non Current Liabilities: 4847000.00
UTI income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: 496000.00
UTI balance_sheet (annual, 2024-09-30) — Other Properties: 288679000.00
UTI balance_sheet (annual, 2024-09-30) — Other Receivables: 3849000.00
UTI balance_sheet (quarterly, 2024-09-30) — Other Receivables: 3849000.00
UTI balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 0.00
UTI income_statement (annual, 2024-09-30) — Otherunder Preferred Stock Dividend: 2855000.00
UTI income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
UTI balance_sheet (annual, 2024-09-30) — Payables: 26273000.00
UTI balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 48206000.00
UTI balance_sheet (annual, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 35660000.00
UTI balance_sheet (annual, 2024-09-30) — Preferred Stock: 0.00